Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Phase III Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Relapsed Follicular Non-Hodgkin's Lymphoma

NCT00078598 is registered in ClinicalTrials.gov with Corixa Corporation as lead sponsor.

NCT NCT00078598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00078598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Phase III Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Relapsed Follicular Non-Hodgkin's Lymphoma
Lead sponsor
Corixa Corporation
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2004
Completion date
Not reported
Enrollment
506
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

non-hodgkin's lymphoma